Heparin Export Market Intelligence: India's 391 Suppliers Shipping to 137 Countries — TransData Nexus 2026

Q: Who are the top heparin exporters from India?

The top heparin exporters from India are: 1. GLAND PHARMA LIMITED — $125.7M (35.6% market share); 2. GLAND PHARMA LTD — $98.0M (27.8% market share); 3. CAPLIN POINT LABORATORIES LIMITED — $31.5M (8.9% market share); 4. PFIZER HEALTHCARE INDIA PRIVATE LIMITED — $25.6M (7.3% market share); 5. MYLAN LABORATORIES LIMITED — $10.7M (3.0% market share). Together they account for 82.6% of India's total heparin export value.

Q: What is the total export value of heparin from India?

The total export value of heparin from India is $352.8M USD, recorded across 4,586 shipment transactions from 391 active exporters to 137 destination countries. The average shipment value is $76.9K.

Q: Which countries import heparin from India?

India exports heparin to 137 countries worldwide. The top importing countries are: UNITED STATES (42.1% share, $148.5M), SAUDI ARABIA (12.3% share, $43.5M), GUATEMALA (8.7% share, $30.6M), THAILAND (7.8% share, $27.3M), PHILIPPINES (4.1% share, $14.4M). These five markets account for 75.0% of total export value.

Q: What is the HS code for heparin exports from India?

The primary HS code for heparin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of heparin exports from India?

The average unit price for heparin exports from India is $58.66 USD per unit, with prices ranging from $0.00 to $24946.48 depending on formulation, packaging, and order volume. The total market is valued at $352.8M across 4,586 shipments.

Q: Which ports handle heparin exports from India?

The primary ports for heparin exports from India are HYDERABAD ICD (14.6% of shipments), SAHAR AIR CARGO ACC (INBOM4) (11.1% of shipments), HYDERABAD ICD (INSNF6) (10.6% of shipments), SAHAR AIR (9.6% of shipments), DELHI AIR CARGO ACC (INDEL4) (4.8% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of heparin?

India is one of the world's leading exporters of heparin due to its large base of 391 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports heparin to 137 countries, demonstrating 70% global market coverage.

Q: What certifications do Indian heparin exporters need?

Indian heparin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import heparin from India?

There are 854 registered buyers importing heparin from India, spread across 137 countries. The repeat buyer rate is 57.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top heparin supplier from India?

GLAND PHARMA LIMITED is the leading heparin exporter from India with a market share of 35.6% and total export value of $125.7M across 763 shipments. The top 5 suppliers together control 82.6% of total export value.

Suresh Sormare

Heparin

India Pharmaceutical Trade Intelligence

$352.8M391 Suppliers137 CountriesHS 30049099

ExportsIndia → UNITED STATES42.1%India → SAUDI ARABIA12.3%

ImportsCHINA → India$508.4B BELGIUM → India$2.8B

#1 Supplier: GLAND PHARMA #1 Buyer: FRESENIUS KABI

Heparin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Heparin to the World

Between 2022 and 2026, India exported $352.8M worth of heparin across 4,586 verified shipments to 137 countries — covering 70% of world markets in the Cardiovascular segment. The largest destination is UNITED STATES (42.1%). GLAND PHARMA LIMITED leads with a 35.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Heparin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Heparin export data snapshot — $352.8M · 391 exporters · 137 countriesTransData Nexus · Indian Customs Data

Top Heparin Exporters from India

391 active exporters · Ranked by export value

View all 391 →

Top Heparin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	GLAND PHARMA LIMITED	$125.7M	763	32	35.6%
2	GLAND PHARMA LTD

Top Countries Importing Heparin from India

137 destination markets · Ranked by import value

All 137 countries →

Top Countries Importing Heparin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$148.5M	42.1%
2	SAUDI ARABIA	$43.5M	12.3%
3	GUATEMALA	$30.6M	8.7%
4	THAILAND	$27.3M	7.8%
5	PHILIPPINES	$14.4M	4.1%
6	PERU	$10.9M	3.1%
7	CHILE	$9.2M	2.6%
8	RUSSIA	$6.6M	1.9%
9	COLOMBIA	$5.7M	1.6%
10	SRI LANKA	$5.5M	1.6%

UNITED STATES is India's largest heparin export destination, absorbing 42.1% of total exports worth $148.5M. The top 5 importing countries — UNITED STATES, SAUDI ARABIA, GUATEMALA, THAILAND, PHILIPPINES — together account for 75.0% of India's total heparin export value. The remaining 132 destination countries collectively receive the other 25.0%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Heparin to India?

17 origin countries · Total import value: $513.9B

India imports heparin from 17 countries with a combined import value of $513.9B. The largest supplier is CHINA ($508.4B, 406 shipments), followed by BELGIUM and FRANCE. All values are from Indian Customs (DGFT) import records.

Countries Supplying Heparin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CHINA	$508.4B	406	98.9%
2	BELGIUM	$2.8B	28	0.5%
3	FRANCE	$2.7B	66	0.5%
4	UNITED STATES	$14.8M	41	0.0%
5	SPAIN	$8.9M	4	0.0%
6	SINGAPORE	$1.2M	3	0.0%
7	ITALY	$1.1M	7	0.0%
8	BRAZIL	$457.2K	3	0.0%
9	IRELAND	$84.8K	2	0.0%
10	UNITED KINGDOM	$7.6K	6	0.0%

Showing top 10 of 17 origin countries

CHINA is the largest supplier of heparin to India, accounting for 98.9% of total import value. The top 5 origin countries — CHINA, BELGIUM, FRANCE, UNITED STATES, SPAIN — together supply 100.0% of India's heparin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Heparin — Export Intelligence Video

Visual overview of India's heparin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's heparin pharmaceutical import and export market — $352.8M in total trade, 391 verified manufacturers, and 137 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Heparin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Heparin, a critical anticoagulant, is extensively utilized in the United States, which accounts for 42.1% of India's heparin exports. The U.S. Food and Drug Administration (FDA) has approved numerous Abbreviated New Drug Applications (ANDAs) for heparin sodium injections, indicating a competitive market with multiple generic manufacturers. The FDA's Orange Book lists several approved ANDAs for heparin sodium, reflecting its widespread acceptance and use.

The regulatory pathway for heparin involves stringent compliance with Current Good Manufacturing Practices (cGMP) and adherence to the United States Pharmacopeia (USP) standards. Indian exporters, totaling 391 active entities, must ensure their manufacturing processes meet these requirements to maintain market access. Notably, the top exporter, GLAND PHARMA LIMITED, holds a 35.6% share of the export value, underscoring the significance of regulatory compliance in sustaining market leadership.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), heparin products require marketing authorization from the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA), respectively. These agencies mandate compliance with the European Pharmacopoeia (EP) standards and adherence to EU Good Manufacturing Practice (GMP) guidelines. Indian exporters must obtain Certificates of Suitability (CEP) to demonstrate compliance with EP monographs, facilitating smoother market entry.

3WHO Essential Medicines & Global Standards

Heparin is included in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025, highlighting its critical role in healthcare systems worldwide. This inclusion underscores the necessity for heparin to meet international pharmacopoeial standards, including those set by the USP, British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Compliance with these standards ensures the quality and efficacy of heparin products in global markets.

4India Regulatory Classification

In India, heparin is classified as a Schedule H drug under the Drugs and Cosmetics Act, requiring a prescription for its dispensation. The National Pharmaceutical Pricing Authority (NPPA) regulates its pricing to ensure affordability. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC), ensuring that domestic supply is not adversely affected by international demand.

5Patent & Exclusivity Status

Heparin, being a naturally derived product, is not subject to patent protection, allowing for the production and export of generic versions. This lack of exclusivity has led to a competitive market landscape, with multiple manufacturers supplying heparin globally.

6Recent Industry Developments

In May 2025, the WHO Expert Committee on Selection and Use of Essential Medicines updated the Model List to its 24th edition, reaffirming heparin's status as an essential medicine. This update emphasizes the ongoing global reliance on heparin for anticoagulation therapy.

In February 2026, the WHO published the report of the 25th Expert Committee on Selection and Use of Essential Medicines, providing comprehensive guidance on the selection and use of essential medicines, including heparin. This report serves as a critical resource for policymakers and healthcare providers worldwide.

These developments highlight the dynamic regulatory environment surrounding heparin and the importance of continuous compliance with international standards to maintain market access and ensure patient safety.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Heparin

Retail & reference prices across 9 markets vs. India FOB export price of $58.66/unit

Global Price Benchmark for Heparin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$20	USD	According to the FDA, heparin is approved for use in various anticoagulant therapies.
United Kingdom	$8–$13	GBP	The National Institute for Health and Care Excellence (NICE) includes heparin in the NHS formulary for approved indications like venous thromboembolism (VTE).
Germany	$9–$14	EUR	Germany’s Federal Joint Committee (G-BA) mandates that heparin prices align with averages from France, Italy, and Spain.
Australia	$10–$13

Supply Chain Risk Assessment — Heparin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including heparin production, heavily relies on China for Key Starting Materials (KSMs). This dependency poses a strategic risk, as disruptions in China's supply chain can halt API synthesis, leading to drug shortages. The 2025 Strait of Hormuz crisis exemplified this vulnerability, with geopolitical tensions causing significant supply chain disruptions.

To mitigate such risks, India has implemented the Production Linked Incentive (PLI) Scheme, aiming to bolster domestic API and KSM manufacturing. This initiative seeks to reduce reliance on imports and enhance supply chain resilience. (pharmanow.live)

2Supplier Concentration & Single-Source Risk

Our data indicates that the top five Indian exporters account for 82.6% of heparin exports, with GLAND PHARMA LIMITED leading at 35.6%. This high concentration increases the risk of supply disruptions if any major supplier faces operational issues. The PLI Scheme is designed to diversify the supplier base by incentivizing new entrants into API manufacturing, thereby reducing single-source dependency. (pharmanow.live)

3Geopolitical & Shipping Disruptions

Access Complete Heparin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 4,586 transactions across 137 markets.

Request Demo View Pricing

Frequently Asked Questions — Heparin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top heparin exporters from India?

The leading heparin exporters from India are GLAND PHARMA LIMITED, GLAND PHARMA LTD, CAPLIN POINT LABORATORIES LIMITED, and 12 others. GLAND PHARMA LIMITED leads with 35.6% market share ($125.7M). The top 5 suppliers together control 82.6% of total export value.

What is the total export value of heparin from India?

The total export value of heparin from India is $352.8M, recorded across 4,586 shipments from 391 active exporters to 137 countries. The average shipment value is $76.9K.

Which countries import heparin from India?

India exports heparin to 137 countries. The top importing countries are UNITED STATES (42.1%), SAUDI ARABIA (12.3%), GUATEMALA (8.7%), THAILAND (7.8%), PHILIPPINES (4.1%), which together account for 75.0% of total export value.

What is the HS code for heparin exports from India?

The primary HS code for heparin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Heparin

Heparin

Top Heparin Exporters from India

Top Countries Importing Heparin from India

Who Supplies Heparin to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Heparin — Export Intelligence Video

Regulatory Landscape — Heparin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Heparin

Supply Chain Risk Assessment — Heparin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

3Geopolitical & Shipping Disruptions

Access Complete Heparin Trade Intelligence

Frequently Asked Questions — Heparin Exports from India

Who are the top heparin exporters from India?

What is the total export value of heparin from India?

Which countries import heparin from India?

What is the HS code for heparin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

4Risk Mitigation Recommendations

What is the average price of heparin exports from India?

Which ports handle heparin exports from India?

Why is India a leading exporter of heparin?

What certifications do Indian heparin exporters need?

How many buyers import heparin from India?

What is the market share of the top heparin exporter from India?

Analysis Methodology